HUP0500995A3 - Casein derived peptides and uses thereof in therapy - Google Patents

Casein derived peptides and uses thereof in therapy

Info

Publication number
HUP0500995A3
HUP0500995A3 HU0500995A HUP0500995A HUP0500995A3 HU P0500995 A3 HUP0500995 A3 HU P0500995A3 HU 0500995 A HU0500995 A HU 0500995A HU P0500995 A HUP0500995 A HU P0500995A HU P0500995 A3 HUP0500995 A3 HU P0500995A3
Authority
HU
Hungary
Prior art keywords
therapy
derived peptides
casein derived
casein
peptides
Prior art date
Application number
HU0500995A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Peptera Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/942,121 external-priority patent/US20020147144A1/en
Application filed by Peptera Pharmaceuticals Ltd filed Critical Peptera Pharmaceuticals Ltd
Publication of HUP0500995A2 publication Critical patent/HUP0500995A2/hu
Publication of HUP0500995A3 publication Critical patent/HUP0500995A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HU0500995A 2001-08-30 2002-08-29 Casein derived peptides and uses thereof in therapy HUP0500995A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/942,121 US20020147144A1 (en) 2000-03-01 2001-08-30 Casein derived peptides and uses thereof in therapy
PCT/IL2002/000720 WO2003018606A2 (en) 2001-08-30 2002-08-29 Casein derived peptides and uses thereof in therapy

Publications (2)

Publication Number Publication Date
HUP0500995A2 HUP0500995A2 (en) 2007-05-02
HUP0500995A3 true HUP0500995A3 (en) 2008-09-29

Family

ID=25477603

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0500995A HUP0500995A3 (en) 2001-08-30 2002-08-29 Casein derived peptides and uses thereof in therapy

Country Status (15)

Country Link
EP (1) EP1556074A4 (enExample)
JP (1) JP2005511499A (enExample)
KR (1) KR20040078639A (enExample)
CN (1) CN1694719A (enExample)
AU (1) AU2002324323A2 (enExample)
BR (1) BR0212625A (enExample)
CA (1) CA2458924A1 (enExample)
CZ (1) CZ2004335A3 (enExample)
HU (1) HUP0500995A3 (enExample)
IL (1) IL160548A0 (enExample)
MX (1) MXPA04001890A (enExample)
NO (1) NO20040880L (enExample)
PL (1) PL375113A1 (enExample)
WO (1) WO2003018606A2 (enExample)
ZA (1) ZA200401574B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0313892D0 (en) * 2003-06-16 2003-07-23 Hannah Res Inst Control of lactation
JP2007525214A (ja) * 2004-01-30 2007-09-06 ケムジェネックス・ファーマシューティカルズ・インコーポレイテッド Ｎ−アセチルトランスフェラーゼ遺伝子型解析によって投与するナフタルイミド
CA2558155A1 (en) * 2004-03-01 2005-09-09 Zvi Sidelman Casein derived peptides and therapeutic uses thereof
GB0423352D0 (en) 2004-10-21 2004-11-24 Hannah Res Inst "Control of mammary cell number"
ES2319475B1 (es) * 2005-06-08 2010-02-16 Consejo Superior Investig. Cientificas Peptidos bioactivos identificados en hidrolizados enzimaticos de caseinas lacteas y procedimiento de obtencion.
US8921310B2 (en) 2006-06-09 2014-12-30 Morinaga Milk Industry Co., Ltd. Method for accelerating mammalian body fat metabolism
JP2011026213A (ja) * 2009-07-22 2011-02-10 Snow Brand Milk Prod Co Ltd １型糖尿病抑制ペプチド
WO2013158553A1 (en) * 2012-04-16 2013-10-24 The Cleveland Clinic Foundation Multivalent breast cancer vaccine
WO2018159546A1 (ja) * 2017-03-03 2018-09-07 森永乳業株式会社 Ｇｌｐ－１分泌促進剤及び組成物
CN107814835B (zh) * 2017-12-01 2020-04-28 熊猫乳品集团股份有限公司 一种生物活性多肽avpitptlnreq及其制备方法和应用
CN108017709B (zh) * 2017-12-12 2020-04-10 浙江辉肽生命健康科技有限公司 一种生物活性多肽kepmigvnqela及其制备方法和应用
CN113952446B (zh) * 2021-09-03 2023-12-05 河南省医药科学研究院 生物活性肽在抑制骨髓毒性中的应用
CN120815163B (zh) * 2025-09-16 2025-12-12 华中科技大学同济医学院附属同济医院 能抑制ccnb2表达的抗肿瘤药物和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3778426A (en) * 1970-12-16 1973-12-11 Research Corp Therapeutically useful polypeptides
NZ332993A (en) * 1997-03-21 2000-01-28 Snow Brand Milk Products Co Ltd Iron-casein complex hydrolyzate and process for the production thereof
IL134830A0 (en) * 2000-03-01 2001-05-20 Chay 13 Medical Res Group N V Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them

Also Published As

Publication number Publication date
PL375113A1 (en) 2005-11-28
CA2458924A1 (en) 2003-03-06
AU2002324323A2 (en) 2003-03-10
CN1694719A (zh) 2005-11-09
WO2003018606A3 (en) 2005-05-06
NO20040880L (no) 2004-04-20
BR0212625A (pt) 2007-06-19
WO2003018606A9 (en) 2004-04-08
JP2005511499A (ja) 2005-04-28
MXPA04001890A (es) 2004-06-18
ZA200401574B (en) 2007-02-28
WO2003018606A2 (en) 2003-03-06
KR20040078639A (ko) 2004-09-10
HUP0500995A2 (en) 2007-05-02
EP1556074A2 (en) 2005-07-27
CZ2004335A3 (cs) 2004-07-14
IL160548A0 (en) 2004-07-25
EP1556074A4 (en) 2008-05-07

Similar Documents

Publication Publication Date Title
HUP0301003A3 (en) Casein derived peptides and uses thereof in therapy
HUP0500992A3 (en) Tacis and br3 polypeptides and uses thereof
EP1461605A4 (en) NANOSTERIALS OF PROTEINS AND PEPTIDES
HUP0500989A2 (en) Animicrobial polypeptides and their uses
AU2002346504A8 (en) Therapeutic protein and treatments
EP1414848A4 (en) REPLICINE PEPTIDES AND ITS USES
HUP0500995A2 (en) Casein derived peptides and uses thereof in therapy
SI1462455T1 (sl) Ser-Ser-Ser-Arg Peptid in zdravilna uporaba le-tega
WO2003099841A9 (en) Peptides and the use thereof in darkening the skin
EP1419175A4 (en) PEPTIDES OF REPLIKIN AND THEIR USE
AU2002233457A1 (en) Non-glycosylated peptides derived from the rsv g protein and use thereof in a vaccine
IL131707A0 (en) Acetylcholinesterase-derived peptides and uses thereof
GB9918155D0 (en) Proteins and peptides
GB0026134D0 (en) Peptides and their use
EP1080185A4 (en) BASIC PROTEIN PEPTIDES OF MYELIN AND THE USE THEREOF.
IL144225A0 (en) ((aminoiminomethyl) amino) alkanecarboxamides and their applications in therapy
IL151351A0 (en) Casein derived peptides and uses thereof in therapy
HK1051501A (en) Casein derived peptides and uses thereof in therapy
GB0102447D0 (en) Protein variants and uses thereof
SG10201403662QA (en) Replikin peptides and uses thereof
GB0108752D0 (en) Peptide epitopes and uses thereof
IL158109A0 (en) Replikin peptides and uses thereof
IL159495A0 (en) Replikin peptides and uses thereof
IL145527A0 (en) Retro-inverso prosaposin-derived peptides and use thereof
AU2001274923A1 (en) Novel human thrombospondin-like proteins and polynucleotides encoding the same

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: PEPTERA PHARMACEUTICALS LTD., IL

Free format text: FORMER OWNER(S): CHAY 13 MEDICAL RESEARCH GROUP N.V., NL